PharmaEssentia Corporation
6446
Clasificación en acciones
#1449
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Precio por acción
$35.96
Capitalización bursátil
$14.87B
Cambio (1 día)
-0.85%
Cambio (1 año)
138.77%
País
TW
Comercio PharmaEssentia Corporation (6446)
Categoría
Healthcare
Historial del precio de la acción de PharmaEssentia Corporation (6446)
Precio más alto de cierre: $37.51 el 2026-10-01
Precio más bajo de cierre: $4.95 el 2014-03-01
Precio más bajo de cierre: $4.95 el 2014-03-01
Historial del precio de la acción de PharmaEssentia Corporation desde 2014 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 78.21% |
| 2025 | -1.54% |
| 2024 | 65.30% |
| 2023 | -34.57% |
| 2022 | 52.79% |
| 2021 | 220.53% |
| 2020 | 2.39% |
| 2019 | -41.63% |
| 2018 | 21.23% |
| 2017 | -8.25% |
| 2016 | -3.31% |
| 2015 | 21.68% |
| 2014 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.01 | 21.90% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $221.29 | 29.22% |
CH
|
|
| $18.45 | -3.94% |
IN
|
